U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
5083350833Effect of Intake of Whey Protein in Elderly Osteopenic Patients. Implications for Metabolism and Physical Function.RecruitingNo Results AvailableOsteopeniaDietary Supplement: Whey protein (HPHL)|Dietary Supplement: Soy protein (HPLL)|Dietary Supplement: Placebo (P)|Other: Resistance traininghttps://ClinicalTrials.gov/show/NCT01900548
5083450834Evaluation and Comparison of the Efficacy of Triphala Mouthwash and 0.2% ChlorhexidineCompletedNo Results AvailablePeriodontal Diseasehttps://ClinicalTrials.gov/show/NCT01900535
5083550835Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable SchizophreniaTerminatedNo Results AvailableSchizophreniaDrug: ITI-214 Dose A|Drug: ITI-214 Dose B|Drug: ITI-214 Dose C|Drug: ITI-214 Dose D (Elderly)|Drug: Placebo|Drug: ITI-214 Dose E|Drug: ITI-214 Dose F|Drug: ITI-214 Dose G|Drug: ITI-214 Dose H|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900522
5083650836Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic MalignanciesRecruitingNo Results AvailableHodgkin Lymphoma|Non-Hodgkin Lymphoma|Acute LeukemiaDrug: Bendamustine|Drug: Clofarabine|Drug: Etoposide|Drug: Etoposide phosphate|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT01900509
5083750837Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin LymphomaRecruitingNo Results AvailableLymphomaDrug: Brentuximab vedotin & Rituximabhttps://ClinicalTrials.gov/show/NCT01900496
5083850838Brain Functions in Patients Before and After Bariatric SurgeryCompletedNo Results AvailableAdiposityhttps://ClinicalTrials.gov/show/NCT01900483
5083950839Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic DiseaseActive, not recruitingNo Results AvailableObesity|Diabetes|Hypertension|Asthma/COPD With Tobacco DependenceBehavioral: CHW Goal Supporthttps://ClinicalTrials.gov/show/NCT01900470
5084050840Vestibular and Multisensory Influence on Bodily and Spatial Representations. Behavioral and Electrophysiological Investigations in Vestibular-defective Patients and Healthy VolunteersCompletedNo Results AvailableVestibular-defective PatientsOther: electromyography|Other: electroencephalography|Other: approaches from psychophysicshttps://ClinicalTrials.gov/show/NCT01900457
5084150841Study of a Booster Dose of IMOJEV® Vaccine One Year After Primary Immunization in Healthy Children in South KoreaCompletedNo Results AvailableJapanese EncephalitisBiological: IMOJEV®: Live Attenuated Japanese Encephalitis Chimeric Virushttps://ClinicalTrials.gov/show/NCT01900444
5084250842Phase II Study to Analyze Sarilumab in Non-Infectious UveitisActive, not recruitingNo Results AvailableUveitisDrug: Sarilumab SAR153191/REGN88|Drug: Prednisone|Drug: Methotrexate|Drug: Folic/folinic acid|Other: Sarilumab (SAR153191/REGN88) placebohttps://ClinicalTrials.gov/show/NCT01900431
5082150821Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4CompletedNo Results AvailableNocturiaDrug: SER120 750 ng|Drug: SER120 1500 ng|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900704
5084350843Physical Activity to Reduce Joint Pain During Aromatase Inhibitor TherapyRecruitingNo Results AvailableJoint Pain|Breast CancerBehavioral: Walk with Easehttps://ClinicalTrials.gov/show/NCT01900418
5084450844Intranasal Dexmedetomidine Sedation for Pediatric CT ImagingRecruitingNo Results AvailableTraumatic Brain Injury|ChildrenDrug: Dexmedetomidinehttps://ClinicalTrials.gov/show/NCT01900405
5084550845Financial Incentives for Maintenance of Weight LossActive, not recruitingNo Results AvailableObesityBehavioral: Financial incentivehttps://ClinicalTrials.gov/show/NCT01900392
5084650846PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular FunctionRecruitingNo Results AvailableHeart Failure|Arteriosclerosis of Coronary Artery Bypass Graft or Other Coronary Reperfusion|Sleep Apnea, ObstructiveProcedure: CPAP treatment|Other: Sham CPAP treatmenthttps://ClinicalTrials.gov/show/NCT01900379
5084750847Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in ObesityRecruitingNo Results AvailableObesityProcedure: Fat Biopsyhttps://ClinicalTrials.gov/show/NCT01900366
5084850848Vertical vs Horizontal Brushing: a Randomized Split-mouth Clinical TrialCompletedNo Results AvailableDental PlaqueOther: brushing methodshttps://ClinicalTrials.gov/show/NCT01900353
5084950849Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in HumansCompletedNo Results AvailableAppetite and General Nutritional DisordersDietary Supplement: Saline|Drug: Exendin 9-39|Dietary Supplement: Saline|Drug: Exendin(9-39) plus ID nutrienthttps://ClinicalTrials.gov/show/NCT01900340
5085050850Neoadjuvant Treatment in Resectable Pancreatic CancerRecruitingNo Results AvailablePancreatic CancerRadiation: External Beam Radiation|Drug: Gemcitabine neoadjuvant|Procedure: Surgery|Drug: Gemcitabine adjuvanthttps://ClinicalTrials.gov/show/NCT01900327
5082250822Removal of the Evolution® Esophageal Stent - Fully CoveredRecruitingNo Results AvailableEsophageal Fistula|Esophageal Neoplasms|Esophageal Perforation|Esophageal Stenosis|StentsDevice: Evolution® Esophageal Stent - Fully Coveredhttps://ClinicalTrials.gov/show/NCT01900691
5082350823A Study of the Safety and Efficacy of the VytronUS Low-Intensity Collimated Ultrasound Ablation SystemCompletedNo Results AvailableParoxysmal Atrial FibrillationDevice: VytronUS Ablation Systemhttps://ClinicalTrials.gov/show/NCT01900678
5082450824Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: Solanezumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01900665
5082550825A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) ParticipantsActive, not recruitingNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: LY2875358|Drug: Erlotinibhttps://ClinicalTrials.gov/show/NCT01900652
5082650826Aspirin AM or PM: Effect on Circadian Rhythm of Platelet ReactivityCompletedNo Results AvailableAspirin|Circadian Rhythm|Platelet Activation|Cardiovascular DiseasesBehavioral: change time of intake of aspirinhttps://ClinicalTrials.gov/show/NCT01900639
5082750827Single vs Double Epidural Catheter Analgesia for Scoliosis SurgeryTerminatedNo Results AvailableAdolescent Idiopathic ScoliosisDrug: epidural catheterhttps://ClinicalTrials.gov/show/NCT01900626
5082850828Niños Sanos, Familia Sana - A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural CaliforniaRecruitingNo Results AvailableObesityBehavioral: Ninos Sanos Familia Sanahttps://ClinicalTrials.gov/show/NCT01900613
5082950829Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)Active, not recruitingNo Results AvailablePrior Acute Myocardial Infarction|Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)|Reduced Left Ventricle Ejection Fraction ( - Other: Cardiopulmonary exercise test|Other: Echocardiogramhttps://ClinicalTrials.gov/show/NCT01900600
5083050830A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) TabletCompletedNo Results AvailableHealthyDrug: Tapentadol ER Tamper-resistant Formulation (TRF)|Drug: Tapentadol ER Prolonged-Release 2 (PR2)https://ClinicalTrials.gov/show/NCT01900587
5083150831A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative ColitisActive, not recruitingNo Results AvailableColitis, UlcerativeDrug: Golimumabhttps://ClinicalTrials.gov/show/NCT01900574
5083250832Optimizing Veteran-Centered Prostate Cancer Survivorship CareRecruitingNo Results AvailableProstate CancerBehavioral: Interactive Voice Response Symptom Management|Behavioral: Tailored Newslettershttps://ClinicalTrials.gov/show/NCT01900561

* Görseller ve İçerik tekif hakkına sahip olabilir